Affiliation: Sun Yat-sen University
- Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancerTingyi Xia
Department of Radiation Oncology, Air Force General Hospital, Beijing, People s Republic of China
Int J Radiat Oncol Biol Phys 66:117-25. 2006..To evaluate the efficacy and toxicity of hypofractionated stereotactic body radiotherapy in patients with Stage I/II non-small-cell lung cancer...
- Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung CancerHongmei Lin
Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China Department of Radiation Oncology, China Japan Friendship Hospital, Beijing, China
Front Oncol 6:260. 2016..Here, we report results of a randomized phase 3 study comparing two CCRT regimens in improving chest tumor control by low-dose paclitaxel chemoradiation for LA-NSCLC...
- SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2Hongqi Li
Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, P R China
Int J Oncol 43:1420-30. 2013....
- [A randomized phase I/II trial to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with locally advanced non-small cell lung cancer]Anhui Shi
Department of Radiation Oncology, Beijing Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China
Zhongguo Fei Ai Za Zhi 14:227-32. 2011..The aim of this study is to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with LANSCLC, and to obtain the best paclitaxel regimen in the concurrent radiochemotherapy...